--- title: "Concentrix (CNXC) Valuation After Q1 2026 Earnings Miss And Profitability Concerns" type: "News" locale: "en" url: "https://longbridge.com/en/news/285470597.md" description: "Concentrix (CNXC) faces scrutiny after its fiscal Q1 2026 earnings missed expectations, revealing strong revenue growth but a significant decline in operating and net income. A secondary sale of 6 million shares by a major shareholder has contributed to market weakness. Currently trading at $23.72, Concentrix is considered undervalued compared to a fair value of $41.25, raising questions about future earnings potential. Analysts highlight risks such as high debt and client concentration, while potential rewards include margin expansion from the Webhelp acquisition. Investors are advised to assess the data carefully before making decisions." datetime: "2026-05-07T02:05:48.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285470597.md) - [en](https://longbridge.com/en/news/285470597.md) - [zh-HK](https://longbridge.com/zh-HK/news/285470597.md) --- # Concentrix (CNXC) Valuation After Q1 2026 Earnings Miss And Profitability Concerns Concentrix (CNXC) is back in focus after its fiscal Q1 2026 earnings. Solid revenue growth contrasted with a sharp drop in operating and net income, prompting a strong market and analyst reaction. See our latest analysis for Concentrix. The Q1 earnings miss and a 6,000,000 share secondary sale by a large shareholder have coincided with sharp weakness. The 30 day share price return of 13.68% and the 1 year total shareholder return decline of 51.2% signal fading momentum after a longer period of pressure. If you are weighing up what else is moving after earnings driven sell offs, this is a good moment to broaden your search with the 19 top founder-led companies With Concentrix trading at US$23.72, a value score of 5, and third party estimates implying a large discount to both price targets and intrinsic value, the key question is whether this weakness is a buying opportunity or if markets already factor in future growth. ## Most Popular Narrative: 42.5% Undervalued With Concentrix last closing at $23.72 against a narrative fair value of $41.25, the current setup centers on whether future earnings can justify that gap. > _The synergies from the Webhelp acquisition and integration are expected to yield margin expansion, with anticipated savings boosting non-GAAP operating margins over time. This contributes to both profitability and cash flow improvements._ _Read the complete narrative._ Want to see what is driving that margin story? The fair value hangs on a sharp swing from losses to sizeable earnings and a different profit profile entirely. **Result: Fair Value of $41.25 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, you still need to weigh modest 2.3% revenue growth assumptions against risks such as high US$4.9b debt and concentration in a few large clients. Find out about the key risks to this Concentrix narrative. ## Next Steps With sentiment split between concern over risks and interest in potential rewards, it makes sense to look closely at the data and decide quickly where you stand, starting with the 3 key rewards and 3 important warning signs ## Looking for more investment ideas? If you are serious about building a stronger portfolio, do not stop with a single stock. Use powerful screeners to quickly surface fresh, data backed ideas before others move. - Target potential mispricings by scanning for companies that combine quality fundamentals with discounted valuations through the 45 high quality undervalued stocks - Strengthen your defensive core by focusing on businesses with robust finances using the solid balance sheet and fundamentals stocks screener (45 results) - Spot under followed opportunities with solid fundamentals before they attract wider attention by running the screener containing 23 high quality undiscovered gems _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### **New:** AI Stock Screener & Alerts Our new AI Stock Screener scans the market every day to uncover opportunities. • Dividend Powerhouses (3%+ Yield) • Undervalued Small Caps with Insider Buying • High growth Tech and AI Companies Or build your own from over 50 metrics. Explore Now for Free ### Related Stocks - [CNXC.US](https://longbridge.com/en/quote/CNXC.US.md) ## Related News & Research - [BUZZ-Concentrix falls on dour quarterly forecast](https://longbridge.com/en/news/280313184.md) - [Concentrix Stock Sinks To 52-Week Low - Here's Why](https://longbridge.com/en/news/280330897.md) - [TKO Group Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/286905283.md) - [Q&A: What Backwardation in Oil Futures Reveals About Market Expectations](https://longbridge.com/en/news/286604883.md) - [Sigma Lithium Announces Record Results for 1Q26: 39% EBITDA Margin; 26% Profitability; 21% of Total Debt Repaid | SGML Stock News](https://longbridge.com/en/news/286560211.md)